<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7102632/results/search/disease/results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
  <result pre="as the COVID-19 resource centre remains active. Abstract As an" exact="atypical" post="pneumonia began to appear in December 2019, Zhou et"/>
  <result pre="the COVID-19 resource centre remains active. Abstract As an atypical" exact="pneumonia" post="began to appear in December 2019, Zhou et al."/>
  <result pre="determine its relationship to animal viruses, and evaluate factors conferring" exact="infection" post="susceptibility and resistance. These foundational results are being advanced"/>
  <result pre="to control the current worldwide human coronavirus epidemic. Within a" exact="short" post="time after recognizing a novel infectious respiratory syndrome in"/>
  <result pre="coronavirus epidemic. Within a short time after recognizing a novel" exact="infectious" post="respiratory syndrome in Wuhan, China, dedicated virologists at the"/>
  <result pre="epidemic. Within a short time after recognizing a novel infectious" exact="respiratory" post="syndrome in Wuhan, China, dedicated virologists at the center"/>
  <result pre="Within a short time after recognizing a novel infectious respiratory" exact="syndrome" post="in Wuhan, China, dedicated virologists at the center of"/>
  <result pre="2019-nCoV RNA virus genome is closely related to the severe" exact="acute" post="respiratory syndrome (SARS)-CoV that emerged in human populations in"/>
  <result pre="RNA virus genome is closely related to the severe acute" exact="respiratory" post="syndrome (SARS)-CoV that emerged in human populations in 2003–2004"/>
  <result pre="virus genome is closely related to the severe acute respiratory" exact="syndrome" post="(SARS)-CoV that emerged in human populations in 2003–2004 to"/>
  <result pre="that emerged in human populations in 2003–2004 to cause epidemic" exact="disease" post="and to several SARS-related CoVs in bats that are"/>
  <result pre="bats that are known to have the potential for human" exact="infection" post="[2]. Thus, 2019-nCoV is now renamed ‘SARS-CoV-2’. It is"/>
  <result pre="over 80 000 individuals as of 25 February 2020. The" exact="infection" post="is associated with a SARS-like disease [3], with a"/>
  <result pre="25 February 2020. The infection is associated with a SARS-like" exact="disease" post="[3], with a case fatality rate at 3.4%. The"/>
  <result pre="[3], with a case fatality rate at 3.4%. The SARS-CoV-2/coronavirus" exact="disease" post="2019 (COVID-19) epidemic has been designated a public health"/>
  <result pre="to detect SARS-CoV-2 infections. Using these methods, they verified the" exact="respiratory" post="tract as a principal infection site and established preliminary"/>
  <result pre="these methods, they verified the respiratory tract as a principal" exact="infection" post="site and established preliminary time courses of virus amplification"/>
  <result pre="time, with abundant virus-specific IgG measured approximately 20 days after" exact="disease" post="onset. These are the findings that help to define"/>
  <result pre="parallel investigations by others demonstrated that SARS-CoV-2 also productively infected" exact="primary" post="human airway epithelial cells [3]. Using in vitro infection"/>
  <result pre="others demonstrated that SARS-CoV-2 also productively infected primary human airway" exact="epithelial" post="cells [3]. Using in vitro infection assays, Zhou et"/>
  <result pre="infected primary human airway epithelial cells [3]. Using in vitro" exact="infection" post="assays, Zhou et al. discovered that convalescent sera from"/>
  <result pre="al. discovered that convalescent sera from surviving patients convincingly neutralized" exact="infections" post="[1]. Moreover, in an initial assessment of broad antibody-mediated"/>
  <result pre="antibody-mediated protection, they found that horse anti-SARS-CoV serum cross-neutralized SARS-CoV-2" exact="infections" post="[1]. Therefore, one can be optimistic about the prospects"/>
  <result pre="[5]. They also reflect the behavior of the Middle East" exact="respiratory" post="syndrome (MERS)-CoV, which, although relying on a distinct dipeptidyl"/>
  <result pre="They also reflect the behavior of the Middle East respiratory" exact="syndrome" post="(MERS)-CoV, which, although relying on a distinct dipeptidyl peptidase"/>
  <result pre="with these susceptibility factors and protect from infection. Figure 1" exact="Severe" post="Acute Respiratory Syndrome (SARS)-CoV-2 Zoonosis and Cell Entry. Bat"/>
  <result pre="these susceptibility factors and protect from infection. Figure 1 Severe" exact="Acute" post="Respiratory Syndrome (SARS)-CoV-2 Zoonosis and Cell Entry. Bat SARS-related"/>
  <result pre="susceptibility factors and protect from infection. Figure 1 Severe Acute" exact="Respiratory" post="Syndrome (SARS)-CoV-2 Zoonosis and Cell Entry. Bat SARS-related CoVs"/>
  <result pre="factors and protect from infection. Figure 1 Severe Acute Respiratory" exact="Syndrome" post="(SARS)-CoV-2 Zoonosis and Cell Entry. Bat SARS-related CoVs (top"/>
  <result pre="Bat SARS-related CoVs (top left) are thought to transmit through" exact="intermediate" post="host(s), with a select subset of viruses having features"/>
  <result pre="subset of viruses having features necessary to infect the human" exact="respiratory" post="tract (top right). Infection (lower panel) requires SARS-CoV-2 spike"/>
  <result pre="features necessary to infect the human respiratory tract (top right)." exact="Infection" post="(lower panel) requires SARS-CoV-2 spike (S) engagement with host"/>
  <result pre="series of conformational changes that result in fusion between the" exact="viral" post="envelope and the target cell membrane. Features of SARS-CoV-2"/>
  <result pre="target cell membrane. Features of SARS-CoV-2 that may facilitate human" exact="infection" post="include: (1) S1B receptor-binding motifs (RBMs) (in green) that"/>
  <result pre="to host protease cleavages [9]. Antiviral antibodies (lower-left inset) prevent" exact="infection" post="by: (a) binding S1B RBMs, blocking receptor access; (b)"/>
  <result pre="models will further address this question, when testing human cell" exact="infection" post="with SARS-related animal CoVs and paying close attention to"/>
  <result pre="important auxiliary cell-binding functions [8]. SARS-CoV-2 S proteins have also" exact="acquired" post="several basic residues (RRAR/S), forming a furin protease cleavage"/>
  <result pre="heightened protease sensitivities account, in part, for SARS-CoV-2 transmissibility and" exact="disease" post="certainly merits further exploration. Quarantine measures are in place"/>
  <result pre="use. If given too late, they may not modify the" exact="disease" post="course, even if virus loads are diminished. Committed research"/>
  <result pre="place and respond appropriately to these challenges. References References 1.ZhouP.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="Sci. U. S. A.11320163048305326976607 3.ZhuN.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N. Engl. J. Med.382202072773331978945 4.ZouL.SARS-CoV-2 viral load"/>
  <result pre="patients with pneumonia in China, 2019N. Engl. J. Med.382202072773331978945 4.ZouL.SARS-CoV-2" exact="viral" post="load in upper respiratory specimens of infected patientsN. Engl."/>
  <result pre="in China, 2019N. Engl. J. Med.382202072773331978945 4.ZouL.SARS-CoV-2 viral load in" exact="upper" post="respiratory specimens of infected patientsN. Engl. J. Med.2020Published online"/>
  <result pre="China, 2019N. Engl. J. Med.382202072773331978945 4.ZouL.SARS-CoV-2 viral load in upper" exact="respiratory" post="specimens of infected patientsN. Engl. J. Med.2020Published online February"/>
  <result pre="Engl. J. Med.2020Published online February 19, 2020. 10.1056/NEJMc2001737 5.LiW.Receptor and" exact="viral" post="determinants of SARS-coronavirus adaptation to human ACE2EMBO J.2420051634164315791205 6.WanY.Receptor"/>
 </snippets>
</snippetsTree>
